Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03025074 · ClinicalTrials.gov registry record
Blood Collection Biorepository for Liver Disease Research
A clinical trial of Hepatitis C and Cirrhosis, sponsored by State University of New York at Buffalo.
- Recruiting
- Registry status
- 1,000
- Enrollment target
- 1
- Study location
NCT03025074: Recruiting study of Hepatitis C and Cirrhosis, sponsored by State University of New York at Buffalo.
NCT03025074 is a study of Hepatitis C and Cirrhosis that is actively recruiting participants, run by State University of New York at Buffalo. The registered enrollment target is 1,000 participants, below the 1,881-participant average among 106 other Hepatitis C trials with a reported enrollment target (47% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03025074, a study of Hepatitis C and Cirrhosis, is actively recruiting participants, sponsored by State University of New York at Buffalo.
- RECRUITING
- Registry status
- 1,000 participants
- Enrollment target
- 1
- Study location
Study Summary
The purpose of establishing a biorepository is to provide high quality specimens (serum, plasma, buffy coat and liver tissue) for future researchers who are studying the effects that fatty liver and viral diseases have on the liver.
Primary Outcome
Total number of samples collected
Conditions Studied
Study Locations (1)
New York
- University at Buffalo, Buffalo General Medical Center - Buffalo
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 1,000 participants |
| Start Date | 2013-07 |
| Est. Completion | 2099-12 |
What NCT03025074 shows while recruiting
NCT03025074 is an observational study that tracks outcomes without assigning an intervention. Its 1,000 participants enrollment target places it among the larger protocols in the corpus, below the 1,881-participant average among 106 other Hepatitis C trials with a reported enrollment target (47% lower).
The record links to 8 conditions, with Hepatitis C appearing as the primary indexed condition, and to 0 interventions.
NCT03025074 reports a single indexed study location in New York.
Frequently Asked Questions
What is clinical trial NCT03025074 about?
NCT03025074 is a clinical study titled "Blood Collection Biorepository for Liver Disease Research". The purpose of establishing a biorepository is to provide high quality specimens (serum, plasma, buffy coat and liver tissue) for future researchers who are studying the effects that fatty liver and viral diseases have on the liver.
What is the current status of trial NCT03025074?
This trial is currently recruiting. The enrollment target is 1,000 participants. The study started on 2013-07. Estimated completion is 2099-12.
What conditions does trial NCT03025074 study?
This clinical trial studies the following conditions: Hepatitis C, Cirrhosis, Obesity, Childhood, Hepatitis B, Bariatric Surgery Candidate.
Who is sponsoring clinical trial NCT03025074?
This trial is sponsored by State University of New York at Buffalo, which has 243 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT03025074 being conducted?
This trial has 1 study location across New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Hepatitis C
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT03025074's enrollment target sits among peer trials
1,000 6th of 106 higher than 100 of 106 other Hepatitis C trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Hepatitis C trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
DBS TaT in Peer-assisted Telemedicine for Hepatitis C
RECRUITING · NA
-
Evaluation of Patients With Liver Disease
RECRUITING
-
The HOPE Study: Characterizing Patients With Hepatitis B and C
RECRUITING
-
Project I Test: Implementing HIV Testing in Opioid Treatment Programs
RECRUITING · NA
-
Partner Navigation Intervention for Hepatitis C Treatment Among Young People Who Inject Drugs
RECRUITING · NA
-
The Treatment in Pregnancy for Hepatitis C ("TiP-HepC") Registry
RECRUITING
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00018044 · 1,000 participants
Study of Mycobacterial Infections
- NCT01036581 · 1,000 participants · NA
Advanced Functional and Structural MRI Techniques for Neuropharmacological Imaging
- NCT01192048 · 1,000 participants
Genetics of Congenital Heart Disease
- NCT01553214 · 1,000 participants · Phase 4
Improving White Blood Cell Collection From Healthy Donors
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia